Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cellular immunity in multiple sclerosis.

× No keyword cloud information.

10 in total

1. Dual response of lymphocytes from multiple sclerosis patients to myelin basic protein.

Authors: V Wicher; W Olszewski; F Milgrom
Journal: Clin Exp Immunol Date: 1979-07 Impact factor: 4.330

2. Influence of the use of statin on the stability of erythrocyte membranes in multiple sclerosis.

Authors: Mariana Vaini de Freitas; Marcela Ramos de Oliveira; Diogo Fernandes dos Santos; Rita de Cássia Mascarenhas Netto; Sheila Bernardino Fenelon; Nilson Penha-Silva
Journal: J Membr Biol Date: 2010-02-10 Impact factor: 1.843

3. Immunological dysfunctions in multiple sclerosis. I. Diminution of 'active' thymus-derived lymphocytes and presence of immunomodulating serum factors.

Authors: J R Kateley; S J Bazzell
Journal: Clin Exp Immunol Date: 1979-02 Impact factor: 4.330

4. Monoclonal antibody analysis of blood T-cell subsets in multiple sclerosis.

Authors: M Zaffaroni; D Caputo; A Ghezzi; S Marforio; C L Cazzullo
Journal: Ital J Neurol Sci Date: 1984-03

5. Past infectious events and disease evolution in multiple sclerosis.

Authors: G Lamoureux; Y Lapierre; G Ducharme
Journal: J Neurol Date: 1983 Impact factor: 4.849

6. On the role of sensitised T-lymphocytes in the pathogenesis of multiple sclerosis.

Authors: A Turner; M L Cuzner; A N Davison; P Rudge
Journal: J Neurol Neurosurg Psychiatry Date: 1980-04 Impact factor: 10.154

7. The geographical distribution of multiple sclerosis, rheumatoid arthritis, rheumatic heart disease and poststreptococcal nephritis in Sardinia: climatic and socioeconomic factors.

Authors: G Rosati; E Granieri; L Pinna; I Aiello; P De Bastiani; R Tola
Journal: J Neurol Date: 1978-09-12 Impact factor: 4.849

8. Multiple sclerosis: I. Monocyte stimulatory defect in mixed lymphocyte reaction associated with clinical disease activity.

Authors: C N Baxevanis; G J Reclos; C Sfagos; E Doufexis; C Papageorgiou; M Papamichail
Journal: Clin Exp Immunol Date: 1987-02 Impact factor: 4.330

9. Linoleic acid therapy in severe experimental allergic encephalomyelitis in the guinea-pig: suppression by continuous treatment.

Authors: D Hughes; A B Keith; J Mertin; E A Caspary
Journal: Clin Exp Immunol Date: 1980-06 Impact factor: 4.330

10. Cell number requirements for lymphocyte stimulation in vitro: changes during the course of multiple sclerosis and the effects of immunosuppression.

Authors: S C Knight; B Harding; S Burman; J Mertin
Journal: Clin Exp Immunol Date: 1981-10 Impact factor: 4.330

10 in total